Abbvie Inc.

Other

Abbvie Bahamas Limited

Abbvie Ireland Unlimited Company

Travis B Dunn

Anthony Ralph Haight

David M Barnes

Vincent S Chan

Shashank Shekhar

Thaddeus Stephan Franczyk, Ii

Sanjay R Chemburkar

Albert Wayne Kruger

Raimundo Ho

Samrat Mukherjee

Niharika Chauhan

Stephen T Chau

Erika Crane

Alex Fabian

Thaddeus S Franczyk

The present invention relates to compositions of elagolix sodium, and process and intermediates for the preparation thereof.

Elagolix sodium compositions and processes

This disclosure is directed to: (a) processes for preparing compounds and salts thereof that, inter alia, are useful for inhibiting hepatitis C virus (HCV); (b) intermediates useful for the preparation of the compounds and salts; (c) pharmaceutical compositions comprising the compounds or salts; and (d) methods of use of such compositions.

Process for preparing antiviral compounds

The disclosure is directed to: (a) phosphacycle ligands; (b) catalyst compositions comprising phosphacycle ligands; and (c) methods of using such phosphacycle ligands and catalyst compositions in bond forming reactions.

Phosphine ligands for catalytic reactions

The disclosure is directed to: (a) phosphacycle ligands; (b) methods of using such phosphacycle ligands in bond forming reactions; and (c) methods of preparing phosphacycle ligands.

This disclosure is directed to: (a) processes for preparing a compound and salts thereof that, inter alia, are useful for inhibiting hepatitis C virus (HCV); (b) intermediates useful for the preparation of the compound and salts; (c) pharmaceutical compositions comprising the compound or salts; and (d) methods of use of such compositions.

Growing community of inventors

Gurnee, IL, United States of America

Travis B Dunn